These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34859929)

  • 1. Pain in irritable bowel syndrome: Does anything really help?
    BouSaba J; Sannaa W; Camilleri M
    Neurogastroenterol Motil; 2022 Jan; 34(1):e14305. PubMed ID: 34859929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral and parenteral anti-neuropathic agents for the management of pain and discomfort in irritable bowel syndrome: A systematic review and meta-analysis.
    Lambarth A; Zarate-Lopez N; Fayaz A
    Neurogastroenterol Motil; 2022 Jan; 34(1):e14289. PubMed ID: 34755926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome.
    Ruepert L; Quartero AO; de Wit NJ; van der Heijden GJ; Rubin G; Muris JW
    Cochrane Database Syst Rev; 2011 Aug; 2011(8):CD003460. PubMed ID: 21833945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary and pharmacological treatment of abdominal pain in IBS.
    Camilleri M; Boeckxstaens G
    Gut; 2017 May; 66(5):966-974. PubMed ID: 28232472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of irritable bowel syndrome.
    Trinkley KE; Nahata MC
    J Clin Pharm Ther; 2011 Jun; 36(3):275-82. PubMed ID: 21545610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.
    Weerts ZZRM; Masclee AAM; Witteman BJM; Clemens CHM; Winkens B; Brouwers JRBJ; Frijlink HW; Muris JWM; De Wit NJ; Essers BAB; Tack J; Snijkers JTW; Bours AMH; de Ruiter-van der Ploeg AS; Jonkers DMAE; Keszthelyi D
    Gastroenterology; 2020 Jan; 158(1):123-136. PubMed ID: 31470006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of abdominal pain in irritable bowel syndrome.
    Vanuytsel T; Tack JF; Boeckxstaens GE
    J Gastroenterol; 2014 Aug; 49(8):1193-205. PubMed ID: 24845149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.
    Black CJ; Yuan Y; Selinger CP; Camilleri M; Quigley EMM; Moayyedi P; Ford AC
    Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):117-131. PubMed ID: 31859183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bulking agents, antispasmodic and antidepressant medication for the treatment of irritable bowel syndrome.
    Quartero AO; Meineche-Schmidt V; Muris J; Rubin G; de Wit N
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003460. PubMed ID: 15846668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome.
    Mozaffari S; Nikfar S; Abdollahi M
    Expert Opin Drug Metab Toxicol; 2013 Apr; 9(4):403-21. PubMed ID: 23330973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis.
    Khanna R; MacDonald JK; Levesque BG
    J Clin Gastroenterol; 2014 Jul; 48(6):505-12. PubMed ID: 24100754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and therapeutic strategies in the irritable bowel syndrome.
    Cremonini F; Talley NJ
    Minerva Med; 2004 Oct; 95(5):427-41. PubMed ID: 15467518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Irritable bowel syndrome: dietary and pharmacological therapeutic options].
    Ducrotté P
    Gastroenterol Clin Biol; 2009 Feb; 33 Suppl 1():S68-78. PubMed ID: 19303541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
    Lewis-Fernández R; Lam P; Lucak S; Galfalvy H; Jackson E; Fried J; Rosario M; de la Cruz AA; Sánchez-Lacay A; Díaz S; Schneier F
    J Clin Psychopharmacol; 2016 Dec; 36(6):710-715. PubMed ID: 27755218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How can we develop better antispasmodics for irritable bowel syndrome?
    Ranjbar S; Seyednejad SA; Nikfar S; Rahimi R; Abdollahi M
    Expert Opin Drug Discov; 2019 Jun; 14(6):549-562. PubMed ID: 30920313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antispasmodics in the treatment of irritable bowel syndrome.
    Annaházi A; Róka R; Rosztóczy A; Wittmann T
    World J Gastroenterol; 2014 May; 20(20):6031-43. PubMed ID: 24876726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2008 Clinical approach to irritable bowel syndrome.
    Astegiano M; Pellicano R; Sguazzini C; Berrutti M; Simondi D; Reggiani S; Rizzetto M
    Minerva Gastroenterol Dietol; 2008 Sep; 54(3):251-7. PubMed ID: 18614974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beliefs about management of irritable bowel syndrome in primary care: cross-sectional survey in one locality.
    Shivaji UN; Ford AC
    Prim Health Care Res Dev; 2015 May; 16(3):263-9. PubMed ID: 25287958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and meta-analysis: efficacy of peppermint oil in irritable bowel syndrome.
    Ingrosso MR; Ianiro G; Nee J; Lembo AJ; Moayyedi P; Black CJ; Ford AC
    Aliment Pharmacol Ther; 2022 Sep; 56(6):932-941. PubMed ID: 35942669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of a Probiotic and an Antispasmodic Increases Quality of Life and Reduces Symptoms in Patients with Irritable Bowel Syndrome: A Pilot Study.
    Barraza-Ortiz DA; Pérez-López N; Medina-López VM; Minero-Alfaro JI; Zamarripa-Dorsey F; Fernández-Martínez NDC; Llorente-Ramón A; Ramos-Aguilar GA
    Dig Dis; 2021; 39(3):294-300. PubMed ID: 32810850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.